Skip to main content

AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs

Pharmaceutical sector-specific exchange traded funds showed mixed results Tuesday after AbbVie (NYSE: ABBV) agreed to acquire Allergan (NYSE: AGN) for $63 billion. Among the largest pharma-specific ETFs, Invesco Dynamic Pharmaceuticals Portfolio (NYSEArca: PJP) was up 0.1%, SPDR Pharmaceuticals ETF...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.